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Summary Hack and Helmy's method for the histochemical identification of NAD(P)H nitroblue tetrazolium
reductase activity was employed to pinpoint reductase activity in certain cells in the mouse. High activity was
observed in the following: lower airway epithelium, liver (centrilobular zone), eyelid (meibomian and
sebaceous glands), vulval gland and parotid gland (striated cells of intralobular ducts). All of these cells had
previously been identified as sites of binding of the reactive metabolites formed from the enzymic reduction of
misonidazole (MISO) (Cobb et al., 1989). It had previously been thought that MISO binding would only take
place in significant amounts in hypoxic tissues (tumour and possibly liver) since in normoxic tissues oxygen
should reverse the initial one electron enzymic reduction, thus preventing progressive reduction to reactive
species. We suggest that the very high levels of reductase in the above listed, probably normoxic, tissues
contribute significantly to the accumulation of bound reactive MISO metabolite(s).
The radiosensitising drug misonidazole [1-(2-nitro- 1-
imidazolyl)-3-methoxy-2-propanol] increases the radiosen-
sitivity of hypoxic cells by virtue of its electron affinity
(Asquith et al., 1974; Hall & Roizin-Towle, 1975; Adams,
1977). This is a non-enzymic process. In anoxic or hypoxic
tissues and in the presence of as yet unidentified nitroreduc-
tases the nitro group of MISO can be progressively reduced
by six electrons to the stable terminal amine. On the way to
complete (6e-) reduction one or more reactive, potentially
cytotoxic, metabolites are formed which bind to macro-
molecules, including DNA, within the reducing cells (Var-
ghese & Whitmore, 1980; Olive, 1979; Miller et al., 1982).
The progression to reactive metabolites is thought to occur
only minimally under aerobic conditions, because the initial
le-nitroreduction is reversed in the presence of oxygen with
the oxidation of the nitro radical anion back to the parent
compound, thus setting up a futile cycle (Mason, 1982;
Franko, 1986). Reduction could theoretically progress to
reactive metabolite(s) even in the presence of oxygen in the
presence of enzymes such as NAD(P)H dehydrogenase
(quinone) (EC 1.6.99.2; DT-diaphorase) which would reduce
MISO by a 2e- step, thus effectively bypassing the futile
cycle.
The formation from MISO, or analogues, of reactive, bin-
ding metabolite(s) in hypoxic tissues has been the subject of
extensive research, in part because of the possibility that with
an appropriate label they could be used to signal the presence
of hypoxic cells in tumours, heart disease and other
pathological states (Chapman et al., 1979; Garrecht & Chap-
man, 1983; Urtasun et al., 1986). Despite major contributions
to our understanding of MISO metabolism (Stratford &
Adams, 1978; Chin et al., 1980; Varghese et al., 1976) we are
still unsure of the nature of the reactive product(s) which
binds to the macromolecules and of the reducing enzymes
(Flockhart et al., 1978; McManus et al., 1982; Rauth, 1984;
Franko, 1986).
In some recent studies of the distribution of 3H- and
'4C-labelled MISO in normal and tumour-bearing mice we
have observed significant amounts of bound metabolite in a
wide variety of tissues, many of which are unlikely to be
hypoxic, e.g. airway epithelium, olfactory epithelium,
sebaceous gland, meibomian gland, vulval gland and parotid
gland duct (Cobb & Nolan, 1989; Cobb et al., 1989, 1990).
In the present work we have attempted to explain this bind-
ing by examining tissues histochemically using the technique
of Hack and Helmy (1964) for identifying NADPH- and
NADH-menadione nitroblue tetrazolium reductase activity.
The reduction of nitroblue tetrazolium (NBT) to formazan
(an ultramarine blue colour) in tissue sections in the presence
of NADPH, or NADH, and menadione may often not be
due to a single reductase. Any of the different reduced
pyridine nucleotide dehydrogenases localised in the mitochon'
dria, microsomes or cytosol can be responsible for the effect
(Schor & Cornelisse, 1983). One of the reasons for using both
NADPH and NADH as cofactors was that one of the can-
didate nitroreductases (NAD(P)H dehydrogenase (quinone),
DT-diaphorase) is known to reduce NBT in cells approx-
imately equally with NADPH or NADH (Schor et al., 1982).
When in the present study the distribution of strongly
staining blue cells was compared with the distribution of
grains (representing bound MISO) in previously reported
autoradiographs of these tissues (Cobb et al., 1989) a good
correlation was seen. This lends weight to our earlier sugges-
tion that the binding of MISO to presumably normoxic
tissue observed 24 h after injection might in part be due to
local high levels of one or more nitroreductive enzymes.
Until recently it was thought that, with the possible exception
of the liver, tumour in tumour-bearing animals or man was
the only tissue to significantly retain bound MISO for any
period of time, and this because parts of it were hypoxic. For
this reason MISO had been put forward as a marker of
hypoxia in tumours.
Materials and methods
Experimental design
Five adult female CBA/H mice aged -14 weeks were used
for the histochemical study. The results of the histochemical
staining were compared with the finding of our two previous
autoradiographic studies in which the same tissues had been
examined for the distribution of bound MISO 24 h after the
intravenous injection of 3H-labelled MISO (Cobb & Nolan,
1989; Cobb et al., 1989). The timing of 24 h had been chosen
because the serum half-life of MISO in the mouse is approx-
imately I h (Chin & Rauth, 1981; Garrecht & Chapman,
1983) and by 24 h only bound MISO would remain - with
the exception of some tritiated water, which would subse-
quently be leached out during the histological preparation
(Franko et al., 1989). The methods for the autoradiograph
studies are detailed elsewhere (Cobb et al., 1989). Briefly, 160
MBq of 3H-MISO labelled on the side chain were injected
into five mice with cold MISO at a dose of 75 or
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750 mg kg-'. After 24 h the mice were killed and the tissues
immediately fixed in formalin. Autoradiographs were
prepared by dipping 7 ,Lm sections of the tissue in K2 emul-
sion (Ilford Nuclear Emulsions, Knutsford, Cheshire, UK).
After exposure periods from 1 to 14 weeks the slides were
developed and grain counts made. The grain count in the
emulsion, per unit area per exposure week, was used as a
measure of the bound labelled MISO in the underlying cells.
Histochemistry
The mice were killed by intraperitoneal pentobarbitone
sodium and the following tissues immediately dissected out,
snap frozen and held in liquid N2 until used: upper and lower
eyelids (voluntary muscle; meibomian and sebaceous glands),
liver, lung, parotid salivary gland and vulva (vulval gland).
For the purposes of sectioning, the tissues were mounted on
the freezing microtome head with OCT embedding medium
(Miles Inc., Elkhart, IN, USA) and 7iLm sections cut at
-20C. Using the Hack and Helmy (1964) method the sec-
tions were fixed in formaldehyde vapour for 30 s to minimise
diffusion of enzyme. They were then incubated at 37°C in
phosphate buffer (pH 7.4) 0.062 M; NBT 0.48 mM; MgCl2
0.05 M; NADPH 0.042 mM or NADH 0.042 mM; and
menadione (vitamin K) 4.2 mM. After 15 min incubation the
sections were terminally fixed in 10% formal saline, washed
in water, and counterstained with 1% methyl green. Finally,
they were rinsed in acetone, dehydrated in alcohols, cleared
in xylene and mounted in DPX (British Drug Houses Ltd,
Poole, Dorset, UK).
Our estimation of the staining density of the various cells
was qualitative. We used an arbitrary scale of 0 to + + + .
The absence of any except minimal blue staining was
recorded as 0, a clearly positive blue stain +, a strong blue
+ + and very strong blue verging on black + + + .
Results
The depth of staining, assessed by eye on a scale 0 to
+ + +, is reported in Table I. There was no detectable
difference between the five mice in the staining density of any
particular tissue.
Table I Staining and grain counts
Grain count
per 100pm2
per exposure
Tissue NADPH NADH week Ratio
Liver
Periportal 0 + 0.6 (0.06)) 4.0 0.91 Centrilobular + + + + + 2.4 (0.12)1 (0)
Lung
Airway + + + +++ 1.5(0.04) 6
Alveoli + a + a 0.22 (0.038) 6 (0)
Parotid gland
Duct ++ ++ 0.184(0.013))24 (.3 Parenchyma 0 0 0.079 (0.004)j 2.43 (0.13)
Meibomian gland + + + + + 13.0 (1.6 ) 68 (14) Stroma 0 0 0.19 (0.03) f) (34) Vulval gland + + + + 4.17 (0.65) )
Sebaceous gland + + 1.6 (0.2
Voluntary muscle 0 +
The grain counts for liver, meibomian gland, stroma, lung (airway)
and sebaceous gland have been previously published (Cobb & Nolan,
1989) and are from mice injected at 750 mg kg-' MISO (rel. spec. act.
74 MBq mg '). The remaining counts are from tissue prepared in the
samestudy but not previously reported. The stroma wasincluded togive
data on background connective tissue levels. The standard error ofthe
mean is in parentheses. The statistical comparisons ofsamples were by
means of Student's t test. All ratios were significantly greater than I
(P<0.0S).a Positivityarose only fromuniformlyscatteredcells, possibly
type II pneumonocytes and/or macrophages. To calculate the grain
count over the alveoli a measurement was first made of the ratio of
alveolar area to alveolar wall and the grain count above alveolar wall
was multiplied by this factor.
Liver
The positive blue staining using either NADPH or NADH
was largely restricted to the centrilobular zone throughout
the liver. This is the same zone in which high MISO binding
had previously been observed (Cobb & Nolan, 1989).
Meibomian (tarsal) gland
This is a large, modified sebaceous gland which discharges
near the base of the eyelashes. The whole gland was seen to
stand out from the neighbouring tissue by virtue of its
positive blue staining (Figure 1). Like the sebaceous and
vulval glands the meibomian gland exhibits holocrine secre-
tion.-That is, the basal cells proliferate, then mature and
hypertrophy, and the whole cell is finally voided through the
duct. The basal cells of the acini were the most strongly
positive. In the mature cells above the basal layer the blue
staining was reduced and was at its lower level when the
grossly enlarged and degenerating cells were at the point of
extrusion into the main ducts. It was, however,
predominantly in the ducts rather than the acini that the
binding of MISO 24 h after injection had been observed. It
should be remembered that the basal cells will in 24 h divide,
mature and progress to the main ducts for secretion. In
unpublished studies we have observed that 2 h after the
injection of 3H-MISO the highest grain counts are over the
basal cells, i.e. where the NBT stain was strongest in the
present study. One other group of cells staining positively in
the eyelid were the stratified epithelial cells of the conjuctival
sac lining. Their retention of MISO was found to be variable.
Figure 1 Meibomian gland. High NADPH tetrazolium reduc-
tase activity in the meibomian gland basal cells (g). The staining
is less as the cells mature (arrows) and progress toward the main
duct (d). The hair follicles of the eyelid (asterisk) are at the top of
the figure and the stratified squamous lining of the conjunctival
sac (c), which in parts stains positively, is to the left. The muscle
of the eyelid (m) is negative, staining only with the counterstain
methyl green. Bar represents 60 tm.526 L.M. COBB et al.
Sebaceous gland
Again the formazan staining was at its heaviest in the basal
cells and became diluted during maturation, as the cells
progressed towards the hair follicle undergoing hypertrophy
and nuclear disintegration on the way (Figure 2). On the
other hand the grain count was highest over the disinte-
grating cells being voided into the hair follicle (Figure 3;
previously published in Cobb et al., 1989).
Vulval gland
As with the previous two tissues the most densely stained
cells were in the base of the acini and staining was reduced as
the cells progressively expanded and degenerated prior to
holocrine secretion. This was in contrast to the autoradio-
graphic studies in which the most dense grain counts were
observed above the degenerating cells in the ducts and not in
the basal cells (Cobb et al., 1989), although in fact the grain
counts in the basal cells were above the surrounding stroma
(Cobb & Nolan, 1989).
Lung
Strong staining of the airway epithelium caused it to stand
out clearly from all other tissues of the lung (Figures 4 and
5). The positive staining extended from the terminal airway
up into the highest point of the trachea that was examined,
i.e. distal third. There did not appear to be a difference in the
staining between the different cell types of the epithelium
(Figure 5) but the staining method might have been
insufficiently sensitive for this degree of discrimination. The
high reductase activity in the airways coincided with the
Figure 2 Sebaceous gland. High NADPH tetrazolium reductase
activity is concentrated at the base of the paired sebaceous glands
(arrow heads). The staining is less dense as the cells mature and
progress towards the hair follicle. The keratinised stratified
squamous epithelium of the skin surface shows some reductase
activity, but the remaining skin components are negative. Bar
represents 45 iLm.
Figure 3 Sebaceous glands (ARG). There is a high grain count
over the mature cells (straight arrows). A reduced, but
significantly above background, grain count is present above the
basal cells (curved arrows). Stain, haematoxylin and eosin. Bar
represents 45gm.
Figure 4 Airway epithelium. NADPH tetrazolium reductase
activity outlining the airway epithelium (double and single
arrows). By contrast the pulmonary veins (v) and arteries (a) are
negative, identifiable only by the methyl green counterstain. Bar
represents 210jlm.
raised grain count which was also observed only in the
airways (Table I and Figure 6), extending from the terminal
airways to the trachea. With neither histochemistry nor
autoradiography was the technique sufficiently precise to be
able to decide whether or not the thin mucociliary layer
above the airway cells was involved.
Parotidgland
The fomazan was observed only over the striated cells which
line the intralobular ducts of the parotid gland (Figure 7).
The striated appearance of these cells at light microscopy isNBT AND MISO BINDING 527
Figure 5 Airway epithelium. NADH tetrazolium reductase Figure 7 Parotid gland. NADH tetrazolium reductase activity in
activity in the terminal airway. The saw-tooth outline of the the lining epithelium of the ducts of the parotid salivary gland
luminal surface is due to the protruding apices of Clara cells (arrows). The staining is heaviest in the basal half of the cells,
(arrow heads). Scattered throughout the alveolar walls are which are densely packed with mitochondria. The cell nuclei
positive staining cells (arrows) which from their distribution appear as clear white circles on the luminal side of the darkly
could be type 11 pneumonocytes or, less likely, lung macrophages. staining basal area. Bar represents 75 pm.
Bar represents 75gAm.
Figure 6 Airway epithelium (ARG). The grains overlying the
epithelium (between arrows) indicate the presence of bound 3H-
MISO metabolite. The lumen of the airway is at the top of the
figure. Stain, haematoxylin and eosin. Bar represents 201Am.
due to densely packed mitochondria in the basal area. These
were also the only parotid gland cells to exhibit a raised
grain count in the autoradiographic studies (Table I).
Voluntary muscle and stroma
Positive staining voluntary muscle in the eyelids was
restricted to approximately 1 in 6 fibres. These were the type
I (slow) fibres which are rich in mitochondria and have
previously been reported to be NBT reductase positive, using
NADH (Bancroft, 1982). These fibres were not associated
with bound MISO in our previous studies. The stroma in all
tissues examined was negative for staining, as it had been for
MISO binding.
Discussion
The present results support our earlier suggestion that the
binding of MISO to apparently well oxygenated tissues could
in part be due to local high nitroreductase activity. Because
the presumed normoxic, MISO-binding, cells were in small
groups or layers it was not feasible to dissect them out for
biochemical analysis. For this reason the histochemical app-
roach has been used. The well established Hack and Helmy
method for NADPH- and NADH-tetrazolium reductase
indicates the presence of one or more dehydrogenases, in-
cluding DT-diaphorase. It has previously been reported that
DT-diaphorase is the only NAD(P)H dehydrogenase which is
equally reduced by either of the two reduced pyridine
nucleotides (Schor et al., 1982). The similarity of staining
using NADPH and NADH as cofactors in the present study
therefore suggests the possibility of nitroreduction by DT-
diaphorase in some of the tissues. However, the nitroblue
tetrazolium stain is not specific and other reductases may
well be involved, e.g. xanthine oxidase, aldehyde oxidase,
cytochrome P-450 reductase and NADPH: cytochrome P-450
(cytochrome c) reductase. In their study of the complete (6e-)
nitroreduction of 2-nitroimidazole benznidazole by mouse
liver Walton and Workman (1987) found that the micro-
somal enzymes NADPH: cytochrome P-450 (cytochrome c)
reductase and cytochrome P-450 mainly were implicated.
These enzymes are most active in the centrilobular zone of
the liver (Van Noorden & Butcher, 1984).
The liver and the gastrointestinal tract are identified as the
prime sites for nitroreduction (Chin & Rauth, 1981). It is
therefore perhaps not surprising that MISO binding has been
observed at high levels in the liver (Chin & Rauth, 1981;
Maxwell et al., 1989; Cobb et al., 1990). On the other hand
Van Os-Corby et al. (1987) were of the view that the liver has
a sufficiently low p02 to produce MISO binding without the
necessity for hypothesising the presence of high levels of
nitroreductase. The relative importance of hepatic reductase
capacity versus low hepatic P02 will not easily be resolved,
particularly as the high reductase activity (and high MISO
binding) we and others have observed is in the same site
within the liver as the likely lowest P02, i.e. centrilobular
zone (Pette & Brandau, 1966; Cobb & Nolan, 1989; Maxwell
et al., 1989). A number of workers have shown that hepatic
nitroreductive enzymes are dependent on either NADPH or
NADH (Gillette et al., 1968; Poirier & Weisburger, 1974).528 L.M. COBB et al.
The sebaceous glands of the hair follicles and the modified
sebaceous tissues, the meibomian and vulval glands, present-
ed a similar histochemical picture, i.e. the highest staining in
the basal cells of the acini with a tailing-off as the cells
approached the ducts. This difference in distribution of
activity is most probably explained by the constant matura-
tion process in these glands. It would appear that maturation
was associated with a loss in NBT reductase actitivty. The
process of maturation might reasonably be expected to take
about 24 h. Therefore, as labelled MISO became bound to
the acinar cells shortly after injection it could be expected to
be found at 24 h in the cells being extruded - which indeed
is where high grain counts were observed. In unpublished
work we have observed uniform grain counts over the acinar
cells, including the basal cells, 2 h after the injection of
3H-MISO.
An incidental finding was positivity in the stratified
epithelium of the skin and conjunctival sac. The subject of
MISO retention in stratified epithelial cells (e.g. skin,
oesophageal and stomach lining) has been raised elsewhere
(Cobb et al., 1989, 1990) and is a complex matter which is
currently under study.
The combination of a high grain count, previously
observed over the lung airway epithelium after the adminis-
tration of 3H-MISO (Table I), and strong formazan staining,
points to the possibility that local high reductase activity was
overwhelming the ability of local oxygen to maintain futile
cycling. An alternative possibility is a 2e- reduction involv-
ing enzymes such as DT-diaphorase effectively bypassing
futile cycling and leading to the production of bound MISO
(Mason, 1982; lyanasi, 1987). We could not identify the
reductase(s) involved although a similar staining pattern with
both NADPH and NADH as substrates pointed to the pos-
sibility of at least some DT-diaphorase activity. Other
enzymes should not be excluded, for example, NADPH
cytochrome P-450 reductase, which has been observed in
high levels in parts of the upper airways in rats (Reed et al.,
1986).
The positive staining of the cells lining the intralobular
duct of the parotid gland mimicked closely the raised grain
count observed in the autoradiographs in the previous
studies. The 3H-MISO appeared to be bound to the striated
cells, so-called because of the dense packing of mitochondria
in the basal half of the cells. The blue stain was also densest
in the basal half of the cells (Figure 7).
The case we are offering for a positive relationship between
high local nitroblue tetrazolium reductase activity and MISO
binding in the apparently normoxic tissues is by no means
proven. Wherever we have previously observed bound MISO
we have in the present histochemical study observed high
NBT reductase activity; but the coincidence could be for-
tuitous. There might in fact be unsuspected hypoxia of many
of these cells. While a possibility in the liver, this would seem
unlikely in much of the airways.
The possibility should be considered that nitroreduction of
MISO and related compounds to cytotoxic species might lead
to cell damage in non-tumorous tissues which have high
reductase capacity. While we have little evidence of this at
present, there are two interesting papers by Knox et al.
(1988a, b) which should be considered. In these they reported
on the nitroreduction of CB1954 5-(aziridin-l-yl)-2, 4-
dinitrobenzamide by DT-diaphorase in the rat. CB1954 is a
cytotoxic drug, with radiosensitising properties, and a nitro
group (Cobb et al., 1969). Our interest in the papers by Knox
et al. stems from the earlier toxicology of this drug in which
histopathological changes were observed in the lung airway
epithelium, the centrilobular areas of the liver, and the lens
epithelium - a tissue lying within eight or so cells of the
meibomian gland secretions (Cobb, 1970). The possibility
exists that high DT-diaphorase levels in these tissues could
have led to these histopathological changes following nitro-
reduction of CB 1954 to its cyctotoxic metabolite.
If MISO is reduced to the reactive metabolite in normoxic
tissues by virtue of a high local reductase capacity, it would
be of interest to examine tumours arising from such tissues
for similarly high or possibly higher levels of reductase.
Schor and colleagues have identified raised DT-diaphorase
levels in hepatomas and Leydig cell tumours in the rat and
mouse (Schor et al., 1976, 1978; Schor & Morris, 1977) and
in man, Koudstaal et al. (1975) and Watternburg (1959) have
observed raised (above parent tissue) levels of NADH-
tetrazolium reductase in colorectal and breast tumours. This
approach is of current interest because of the development of
bioreductive drugs for anti-tumour therapy (Stratford et al.,
1986; Adams & Stratford, 1988). It would seem that
bioreductive drugs might fruitfully make headway in the area
of high reductase tumours because of the possibility of
activating pro-drugs in the normoxic as well as in the
hypoxic cells.
We wish to thank Dr David Papworth for his statistical analyses and
Dr Keith Morris for the calculation of alveolar wall area using the
Seescan image-analyser.
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